Literature DB >> 30195990

Psychophysical evaluation of contrast sensitivity using Gabor patches in tobacco addiction.

Thiago Monteiro Paiva Fernandes1, Steven M Silverstein2, Natalia Leandro de Almeida3, Natanael Antonio Dos Santos1.   

Abstract

This study, an extension of Fernandes et al. (2017), provided consistent contrast sensitivity function (CSF) measurements in a large sample. CSF was assessed for luminance stimuli in different 48 chronic smokers and 50 healthy nonsmokers. Stimuli for the CSF were Gabor patches with spatial frequencies of .2, 2.5, 5.0, 10.0, and 20.0 cycles per degree (cpd). The use of Gabor patches minimizes uncertainty in spatial position and detection of frequencies. The Gabor patches consisted of vertical gratings that were multiplied by a two-dimensional spatial Gaussian envelope. All of the groups were matched for gender and level of education. All of the participants were free from any neurological disorder, cardiovascular disease, and identifiable ocular disease, and they had normal or corrected-to-normal visual acuity. No abnormalities were detected on the fundoscopic examination or optical coherence tomographic examination. The smoker group had a lower CSF compared with healthy nonsmokers at all spatial frequencies. These results indicate that cigarette smoking or chronic exposure to its constituent compounds affects early-stage visual discrimination, suggesting the existence of deficits in early visual spatial processing in smokers.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cigarette smoking; Psychophysics; Smoking; Visual perception

Mesh:

Year:  2018        PMID: 30195990     DOI: 10.1016/j.jocn.2018.08.034

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Combined influence of illness duration and medication type on visual sensitivity in schizophrenia.

Authors:  Natalia L Almeida; Thiago P Fernandes; Eveline H Lima; Hemerson F Sales; Natanael A Santos
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.